Sudarshan Pharma Industries Ltd — Important, 04-06-2026: Company Update

Sudarshan Pharma has announced its financial results for the quarter and half-year. The company reported full-year consolidated total revenue of Rs. 502.49 Cr and a net loss of Rs. 0.0203 Cr. Operationally, it received Rs. 4.65 Cr from a Dubai court award, with the remaining balance to be collected. The Board has also approved raising up to Rs. 1,500 Cr via FCCBs, securing new RBI approval for this fund-raising. Additionally, the company acquired an API manufacturing facility in Telangana for Rs. 25.50 Cr, enhancing its operational footprint.